Crescita Therapeutics (TSX:CTX) Price-to-Tangible-Book : 0.51 (As of May. 25, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Price-to-Tangible-Book?

As of today (2024-05-25), Crescita Therapeutics's share price is C$0.43. Crescita Therapeutics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was C$0.84. Hence, Crescita Therapeutics's Price to Tangible Book Ratio of today is 0.51.

The historical rank and industry rank for Crescita Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

TSX:CTX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.51 Med: 0.95 Max: 2.57
Current: 0.51

During the past 10 years, Crescita Therapeutics's highest Price to Tangible Book Ratio was 2.57. The lowest was 0.51. And the median was 0.95.

TSX:CTX's Price-to-Tangible-Book is ranked better than
95.49% of 865 companies
in the Drug Manufacturers industry
Industry Median: 2.32 vs TSX:CTX: 0.51

A closely related ratio is called PB Ratio. As of today, Crescita Therapeutics's share price is C$0.43. Crescita Therapeutics's Book Value per Sharefor the quarter that ended in Mar. 2024 was C$0.93. Hence, Crescita Therapeutics's P/B Ratio of today is 0.46.

Crescita Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Crescita Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Price-to-Tangible-Book Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.42

0.88

0.81

0.74

0.58

Crescita Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															0.73	0.73	0.74	0.58	0.54

Competitive Comparison of Crescita Therapeutics's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Crescita Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Crescita Therapeutics's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Crescita Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Crescita Therapeutics's Price-to-Tangible-Book falls into.

Crescita Therapeutics Price-to-Tangible-Book Calculation

Crescita Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	0.43	/	0.838
	=	0.51

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Crescita Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics (TSX:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

CRRTF:USA

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.

Executives

Knight Therapeutics Inc.

10% Security Holder

Crescita Therapeutics (TSX:CTX) Headlines

No Headlines